Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04020185
Title Safety and Efficacy Study of IMSA101 in Refractory Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ImmuneSensor Therapeutics Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Honor Health Scottsdale Arizona 85260 United States Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Atlantic Health System/Morristown Medical Center Morristown New Jersey 07962 United States Details
UT Southwestern Dallas Texas 75390 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field